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ABSTRACT 
Nanotechnology is a multi disciplinary science which is getting considerable attention in development of new chemical entities, 
diagnosis and treatment of several ailments. Nanomedicine technology has developed many drug delivering systems like 
nanoparticles, nanoemulsions, nanosuspensions, nanosponges etc., which are associated with many advantages including improved 
bioavailability. Nanosponges are tiny sponges having size of about a virus and can be filled with variety of drugs. This sponge can 
circulate around the body until interact with specific target site and stick on surface and start releasing drug in a controlled manner.  
 Nanosponge play vital role in targeting drug delivery in a controlled manner. Both lipophilic and hydrophilic drugs are 
incorporated in nanosponges. The outer surface is typically porous, allowing controlled release of drug. Important characteristic of 
these sponges is their solubility in aqueous form and suitable for the drugs with poor solubility. This review is focusing on the 
preparation methods, applications of nanosponges in the field of drug delivery.  
Keywords: Nanosponges, nano delivery, targeted site. 
 
INTRODUCTION 
The drug delivery technology has certainly a new   
interest for drugs by providing them new life through 
their therapeutic targets. Targeting drug delivery is the 
major problem which is being faced by the researchers. 
Target oriented drug improvements in therapeutic 
efficacy, reduction in side effects and optimized dosing 
regimen, shall be the leading trends in the area of 
therapeutics
1
. Targeted drug delivery implies for 
selective and effective localization of 
pharmacologically active moiety at preidentified 
(preselected) target in therapeutic concentration, while 
restricting its access to non-target normal cellular 
linings and thus minimizing toxic effects and 
maximizing therapeutic index of the drug
2
. They 
provide excellent topical delivery of drugs
3
. These 
embraces nanotechnology which is applied to 
pharmacy as nano materials, diagnosing and focusing 
right place in the body and controlling release of the 
drug
4
. Nanosponges is about the size of virus which 
has been backed by naturally degradable polyster. 
These tiny sponges can circulate around the body they 
encounter the specific target site and stick on the 
surface and began to release the drug in a controlled 
and predictable manner. Owing to their small size and 
porous nature they can bind poorly- soluble drugs 
within the matrix and improve their bioavailability. 
These are solid in nature and it can be formulated as 
oral, parenteral, topical or inhalational dosage forms. 
For oral administration, nanosponges may be dispersed 
in a matrix of excipients, diluents, lubricants and anti-
caking agents which is suitable for the preparation of 
tablets or capsules.  
 
Figure 1: Structure of Nanosponge 
For parenteral administration, these can be simply 
mixed with sterile water, saline or other aqueous 
solutions. For topical administration, they can be 
effectively incorporated into topical hydrogel
5
.   
Advantages
 
 
1. This technology offers entrapment of ingredients and 
reduces side effects
6
.  
2. Improved stability, increased elegance and enhanced 
formulation flexibility.  
3. These formulations are stable over range of pH 1 to 
11.  
4. These formulations are stable at the temperature up 
to 130
0
C.  
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5. These formulations are compatible with most 
vehicles and ingredients
7
.  
6. These are self sterilizing as their average pore size is 
0.25¼m where bacteria cannot penetrate.  
7. They increase the bioavailability of drug
8
. 
8. These modify the release of drug.  
9. They increase the solubility of poorly soluble drug.  
Disadvantages: 
1) Nanosponges include only small molecules
9
. 
2) Depend only upon loading capacities. 
 
Table 1: Chemicals used for the synthesis of 
nanosponges 
Polymers  
 
Hyper cross linked Polystyrenes, 
Cyclodextrines and its derivatives like 
Methyl β-Cyclodextrin, 
Alkyloxycarbonyl Cyclodextrins, 2-
Hydroxy Propyl β-Cyclodextrins and 
Copolymers like Poly(valerolactone-
allylvalerolactone) and 
Poly(valerolactone 
allylvalerolactoneoxepanedione), Ethyl 
Cellulose and PVA 
Crosslinkers Diphenyl Carbonate, Diarylcarbonates, 
Diisocyanates, Pyromellitic anhydride, 
Carbonyldiimidazoles, Epichloridrine, 
Glutarldehyde, Carboxylic acid 
dianhydrides, 2,2- bis(acrylamido) 
Acetic acid and Dichloromethane 
Apolar 
solvents  
Ethanol, Dimethylacetamide, Dimethyl 
formamide 
 
SYNTHESIS OF NANOSPONGES  
It is one of the important criteria for the formation of 
product obtained activity in β-cyclodextrin, titanium 
oxide.  
1.  Solvent method  
The solvent required is mixed with the polymer mainly 
in a polar aprotic solvent, for example dimethyl 
formide, dimethyl sulfoxide then add this mixture to 
cross linker in a exceed quantity, the ratio for cross 
linker/ molar ratio is preferred as 4 to 16. The reaction 
is proceeded with a solvent reflux temperature and time 
ranging from 1 to 48 hr. The cross linkers which may 
preffered are dimethyl carbonate and carbonyl di-
imidazole
10
. The reaction is completed and solution is 
allow to cool at room temperature then product is 
added to excess of bi-distilled water and product is 
recovered by filtration under vaccum and 
simultaneously purify by prolonged soxhlet extraction 
with ethanol. Finally product is dried under vaccum 
and grinded in a mechanical mill to obtain 
homogeneous powder
11
. 
2. Ultrasound assisted synthesis 
Nanosponges are obtained by reacting polymer with 
cross linkers without adding or without using solvent 
and sonification is maintained. The polymer is mix 
with a cross linkers in a balanced ratio in a flask. The 
flask is placed in a molar ratio in an ultrasound bath 
field with water and temperature maintained at 90 ºC, 
the mixture is sonicated for 5 hrs
12
. Then the mixture is 
kept to cool and product is break roughly then the 
product is washed with water to remove non-reacted 
polymer and subsequently purified by soxhlet 
extraction with ethanol. The product is dried under 
vaccum at 25ºC until its further use is utilized
13
.
 
 
3. Loading of drug into nanosponges  
Nanosponges obtained should be pretreated to maintain 
mean particle size blow 500nm. Nanosponges are 
suspended in water and were sonicated to avoid 
presence of aggregates and particles and got 
centrifuged to obtain colloidal fraction, then 
supernatant is separated and dried sample by freezing 
by drying
14
. Further proceeding start with preparing 
aqueous suspension of  nanosponges and excess 
amount of drug is dispensed for maintaining 
suspension under constant stirring for specific time 
period for complexation is over the undissolved drug 
(uncomplexed condition) is separated from complexed 
drug with the process of centrifugation. This process 
helps in evolving solid crystals of nanosponges by 
solvent evaporation or freeze drying. Para-crystalline 
nanosponges revealed different loading capacities 
when compared to crystalline nanosponges poorly 
crystalline nanosponges had act drug loading as a 
mechanical mixture rather than inclusion complex
15
. 
 
FACTORS INFLUENCE NANOSPONGE 
FORMATION 
1. Type of polymer  
Type of polymer used can influence the formation as 
well as the performance of Nanosponges. For 
complexation, the cavity size of nanosponge should be 
suitable to accommodate a drug molecule of particular 
size
16
. 
2. Type of drugs 
Drug molecules to be complexed with nanosponges 
should have certain characteristics mentioned below
17
- 
• Molecular weight between 100 and 400 
• Drug molecule consists of less than five condensed 
rings 
• Solubility in water is less than 10mg/mL 
• Melting point of the substance is below 250°C 
3. Temperature 
Temperature changes can affect drug/nanosponge 
complexation. In general, increasing in the temperature 
decreases the magnitude of the apparent stability 
constant of the drug/ nanosponge complex may be due 
to a result  
of possible reduction of drug/ nanosponge interaction 
forces, such as Van-der Waal forces and hydrophobic 
forces with rise of temperature
18
. 
 
PHYSICOCHEMICAL CHARACTERIZATION 
OF NANOSPONGE  
1. Particle size determination  
Free-flowing powders with fine aesthetic attributes will 
possible to obtain by controlling the size of particles 
during polymerization. Particle size analysis of loaded 
and unloaded nanosponges will performed by laser 
light diffractometry or Malvern Zeta sizer. Particles 
larger than 30 m can impart gritty feeling and hence 
particles of sizes between 10 and 25 m are preferred to 
use in final topical formulation
19
. 
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2. Determination of loading efficiency and 
production yield
 
 The prepared nanosponge loading efficiency is 
determined by subtracting the un-entrapped drug from 
the total amount of drug. The drug entrapment 
efficiency will be determined by separating un-
entrapped drug estimated by any suitable method of 
analysis
20
. The method used for separation of un-
entrapped drug by gel filtration, dialysis and ultra 
centrifugation
21
.  
3. Porosity   
Porosity study is performed to check the extent of 
nanochannels and nanocavities formed. Porosity of 
nanosponges is assessed with a helium pycnometer, 
since helium gas is able to penetrate inter- and intra-
particular channels of materials. The true volume of 
material isdetermined by the helium displacement 
method. Owing to their porous nature, nanosponges 
exhibit higher porosity compared to the parent polymer 
used to fabricate the system
22
.  
 4. Swelling and water uptake 
For swellable polymers like polyamidoamine 
nanosponges, water uptake can be determined by 
soaking the prepared nanosponges in aqueous 
solvent
23
. Swelling and water uptake can be calculated 
using equations: 
 
 
 
5. Resiliency (Viscoelastic properties)  
Resiliency of sponges can be modified to produce 
beadlets that is softer or firmer according to the needs 
of the final formulation. Increased crosslinking tends to 
slow down the rate of release. Hence resiliency of 
sponges will be studied and optimized as per the 
requirement by considering the release as a function of 
cross-linking with time
24
. 
6. Zeta Potential 
Zeta potential is a measure of surface charge. The 
surface charge of nanosponges can be determined by 
using Zeta sizer
25
. 
 7. In vitro release studies 
Dissolution profile of Nanosponge can be studied by 
use of the dissolution apparatus usp XXIII with a 
modified basket consisted of 5m stainless steel mesh. 
Speed of the rotation is 150 rpm. The dissolution 
medium is selected while considering solubility of 
actives to ensure sink conditions. Samples from the 
dissolution medium can be analyzed by a suitable 
analytical method studied by use of the dissolution 
apparatus USP xxiii with a modified basket consisted 
of 5m stainless steel mesh. Speed of the  
rotation is 150 rpm. The dissolution medium is selected 
while considering solubility of actives to ensure sink 
conditions. Samples from the dissolution medium can 
be analyzed by a suitable analytical method
26
. 
 8. Permeation studies 
The diffusion studies of the prepared nanosponge can 
be carrying out in Franz diffusion cell for studying the 
dissolution release of nanosponge through a cellophane 
membrane. Nanosponge sample (0.5g) can taken in 
cellophane membrane and the diffusion studies were 
carried out at 37±1°C using 250 ml of phosphate buffer 
(pH 7.4) as the dissolution medium. 5ml of each 
sample can withdrawn periodically at 1, 2, 3, 4, 5, 6, 7 
and 8 hrs and each sample will replaced with equal 
volume of fresh dissolution medium
27
. 
 
APPLICATIONS OF NANOSPONGES 
1. Nanosponges for drug delivery
 
Because of their nonporous structure, nanosponges can 
advantageously carry water insoluble drugs 
(Biopharmaceutical Classification System class-II 
drugs). These complexes can be used to increase the 
dissolution rate, solubility and stability of drugs, to 
mask unpleasant flavors and to convert liquid 
substances to solids
28
.  
 2.  Nanosponges as chemical sensors 
Nanosponges which are the type of “metal oxides” act 
as a chemical sensors which is used in highly sensitive 
detection of hydrogen using nanosponge titania. 
Nanosponge structure intially have no point of contact 
so there is less hinderance to electron transport and it 
results in higher 3D interconnect nanosponges titania 
which is sensitive to H2 gas
29
. 
3.  Nanpsponge for oral delivery  
In oral application it forms the nanosponge system 
consist of pores which increase the rate of 
solubilization of poorly water soluble drugs which get 
entrapped the drug in pores. The surface area is 
increased due to nanosize form and increase rate of 
solubilization
30
. 
4. Solubility enhancement  
β-cyclodextrin based nanosponges of itraconazole have 
enhance solubility of poorly soluble drug. The 
solubility increased by 50 folds compared to ternary 
dispersion system e.g. - copolyvidonum
30
. 
5. Nanosponges as a carrier for biocatalysts and 
release of enzymes, proteins, vaccines and 
Antibodies  
It includes the process applied in industry which 
correlates with operational condition. Reactions which 
are not specific give rise to low yields and require high 
temperatures and pressures which consume large 
amount of energy and cooling water in down-stream 
process. This are the drawbacks can be removed by 
using enzymes as biocatalysts as this operate under 
high reaction speed, mild condition
31
. 
6.  Antiviral application 
Nanosponges used in nasal, pulmonary route of 
administration. It provide specificity to deliver antiviral 
drug on RNA to lungs or nasal route through 
nanocarriers for targeting virus which may cause 
infection to RTI such as influenza virus, rhinovirus. 
Drugs used as nanocarrriers are- Zidovudine, 
Saquinavir
32
. 
7.  Cancer  
Targeting drug to specific site avoiding the obstacle 
created by immune system. Different cancer cells had 
been treated by nanosponges like breast cancer or fast 
acting glioma type with help of single dose of 
injections
33
. 
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8. Oxygen Delivery System 
Characterized by using α, β and ϒ cyclodextrins and 
this are suspended in water and get saturated with 
water. A silicone form of membrane can also be used 
for oxygen permeation with the help of nanosponge/ 
hydrogel system
34
.  
 
CONCLUSION 
Nanosponges are tiny mesh-like structures that may 
revolutionise the treatment of many diseases and this 
technology is five times more effective at delivering 
drugs for cancer than conventional methods. Because 
of their small size and spherical shape nanosponges can 
be developed as different dosage forms like parenteral, 
aerosol, topical, tablets and capsules. Nanosponge are 
nano sized colloidal carrier so they easily penetrate 
through skin. The nanosponges have the ability to 
include either lipophilic or hydrophilic drugs and 
release them in a controlled and predictable manner at 
the target site. The nanosponges have the ability to 
incorporate many drugs and release them in a 
controlled and predictable manner at the target site. 
Topical nanosponge can be more patient compliant and 
provide sufficient patient benefits by reducing repeated 
doses and side effects. Nanosponge can be effectively 
incorporated into topical drug delivery system for 
retention of dosage form on skin. Hence present study 
concludes that nanosponges may play an important role 
for the treatment of different diseases. 
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